Featured

Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular Risks



Published
Chair, Norman E. Lepor, MD, FACC, FAHA, FSCAI, discusses hyperlipidemia in this CME activity titled “Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at PeerView.com/TVJ865. CME credit will be available until September 28, 2023.
Category
Management
Be the first to comment